|1.||Baumann, Wolfgang: 6 articles (06/2012 - 06/2004)|
|2.||Togha, Mansoureh: 5 articles (10/2014 - 04/2008)|
|3.||Schwarz, Mario: 5 articles (01/2008 - 06/2004)|
|4.||Ashrafi, Mahmoud Reza: 3 articles (10/2014 - 03/2012)|
|5.||Savage, Julian: 3 articles (01/2012 - 01/2007)|
|6.||Jüngling, Eberhard: 3 articles (12/2009 - 06/2004)|
|7.||Lückhoff, Andreas: 3 articles (12/2009 - 06/2004)|
|8.||Westhofen, Martin: 3 articles (12/2009 - 06/2004)|
|9.||Teggi, R: 2 articles (10/2015 - 10/2014)|
|10.||Gatti, O: 2 articles (10/2015 - 10/2014)|
|1.||Vertigo (Positional Vertigo)
05/01/2002 - "Cinnarizine treatment decreased the incidence of moderate vertigo episodes by 65.8% and decreased severe vertigo episodes by 89.8%. "
06/01/2005 - "On the other hand, cinnarizine is a blocker of voltage-gated Ca2+ currents in hair cells and is used as a drug in conditions with vestibular vertigo. "
06/01/2004 - "We conclude that these direct actions of cinnarizine on hair cells should be considered as molecular mechanisms contributing to therapeutic effects of cinnarizine in vertigo."
01/01/1989 - "12 patients out of 20 treated with 75 mg Cinnarizine twice a day during seven days demonstrated satisfactory vertigo suppression versus only 5 out of 20 treated with placebo. "
01/01/1989 - "[Effect of cinnarizine on various types of vertigo. "
|2.||Motion Sickness (Airsickness)
07/01/1994 - "In conclusion, cinnarizine 50 mg was found to be effective in the prevention of seasickness in rough seas."
06/01/1994 - "Seasickness symptoms were improved in 69% of the subjects by 50 mg cinnarizine versus 35% and 31% in the groups receiving 25 mg cinnarizine and placebo (p < 0.05 and p < 0.01, respectively). "
07/01/1994 - "In a double-blind, placebo-controlled study, we evaluated the effect of two different doses of cinnarizine in the prevention of seasickness in very rough seas. "
06/01/1994 - "Cinnarizine was evaluated for the prevention of seasickness in a laboratory and sea study. "
06/01/1994 - "Cinnarizine in the prophylaxis of seasickness: laboratory vestibular evaluation and sea study."
|3.||Migraine Disorders (Migraine)
10/01/2014 - "Our results indicate that the use of cinnarizine at doses administered in this study is effective and safe for prophylaxis of migraine headaches in children."
10/01/2014 - "A placebo-controlled trial was conducted to demonstrate the efficacy and safety of cinnarizine in the prophylaxis of migraine in children. "
10/01/2014 - "Efficacy and safety of cinnarizine in the prophylaxis of migraine in children: a double-blind placebo-controlled randomized trial."
03/01/2006 - "Sixty patients with more than 2 migraine headache attacks during a 4-week baseline entered the study and received a 25-mg tablet cinnarizine twice daily for the first 3 days and then 3 times daily. "
03/01/2006 - "Open-label trial of cinnarizine in migraine prophylaxis."
10/01/2014 - "However, compared with 31.3% of children in the placebo group, 60% of children in the cinnarizine group reported more than 50% reduction in monthly headache frequency (P = 0.023), suggesting that cinnarizine was significantly more effective than placebo in reducing the frequency of headaches. "
01/01/1977 - "The use of stugeron for preventive treatment of migrain cephalgia was effective in 85 of the 100 treated patients and especially in those cases where there was an increased tone of the cerebral vessels according to the REG data. "
10/01/2014 - "After 3 months of taking cinnarizine or placebo, children in both groups experienced significantly reduced frequency, severity, and duration of headaches compared with baseline measurements (P < 0.001). "
03/01/2012 - "Cinnarizine reduced the baseline headache frequency by more than 50% in 74.6% of patients and the mean headache frequency per month was reduced from 11.851 ± 0.739 (mean ± SEM) to 3.358 ± 0.739 (mean ± SEM) attacks per month (P < 0.001). "
01/01/1977 - "[Rheoencephalographic findings in migrainous cephalalgia and their dynamics during treatment with stugeron]."
05/01/1991 - "Within the limitations of the sample study, our results indicate that the biofeedback method is more effective in comparison with acupuncture and Cinnarizine in the treatment of those suffering from tinnitus."
05/01/1991 - "The findings show that at the end of treatment, 50% of the patients in the biofeedback group reported some amelioration in the level of the tinnitus, while 30% of the acupuncture group and only 10% of the group receiving Cinnarizine reported an amelioration of the tinnitus. "
05/01/1991 - "The effect of three treatment modalities of idiopathic-subjective tinnitus (IST): acupuncture (AP), biofeedback (BF) and Cinnarizine (Cin), was investigated in 58 randomly selected subjects. "
01/01/1999 - "We were interested in determining the efficacy of Arlevert therapy in vertigo and tinnitus patients, especially as it compared to the efficacy of the drug's two component agents, dimenhydrinate and cinnarizine. "
01/01/2002 - "In a randomized, double-blind clinical study, we evaluated the efficacy and tolerability of the fixed combination of cinnarizine, 20 mg, and dimenhydrinate, 40 mg (Arlevert [ARL]) in comparison to betahistine dimesylate (12 mg) in 82 patients suffering from Ménière's disease for at least 3 months and showing the characteristic triad of symptoms (paroxysmal vertigo attacks, cochlear hearing loss, and tinnitus). "
|4.||Vasodilator Agents (Vasodilators)
|6.||Calcium Channels (Calcium Channel)
|7.||Valproic Acid (Valproate, Semisodium)
|8.||dimenhydrinate drug combination cinnarizine
|1.||Psychology Biofeedback (Biofeedback)
|2.||Drug Therapy (Chemotherapy)
|4.||Hearing Aids (Hearing Aid)
|5.||Medication Errors (Medication Error)